What Analysts Are Saying About AMETEK Stock
11 analysts have expressed a variety of opinions on AMETEK (NYSE:AME) over the past quarter, offering a diverse set of opinions from bullish to bearish.
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 2 | 5 | 4 | 0 | 0 |
| Last 30D | 0 | 0 | 0 | 0 | 0 |
| 1M Ago | 0 | 3 | 2 | 0 | 0 |
| 2M Ago | 2 | 0 | 0 | 0 | 0 |
| 3M Ago | 0 | 2 | 2 | 0 | 0 |
The 12-month price targets, analyzed by analysts, offer insights with an average target of $223.0, a high estimate of $240.00, and a low estimate of $204.00. Marking an increase of 6.74%, the current average surpasses the previous average price target of $208.91.

Analyzing Analyst Ratings: A Detailed Breakdown
In examining recent analyst actions, we gain insights into how financial experts perceive AMETEK. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
| Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
|---|---|---|---|---|---|
| Christopher Snyder | Morgan Stanley | Raises | Equal-Weight | $215.00 | $198.00 |
| Julian Mitchell | Barclays | Raises | Equal-Weight | $210.00 | $205.00 |
| Steve Barger | Keybanc | Raises | Overweight | $235.00 | $220.00 |
| Steve Barger | Keybanc | Raises | Overweight | $235.00 | $220.00 |
| Brett Linzey | Mizuho | Raises | Outperform | $230.00 | $225.00 |
| Joseph Giordano | TD Cowen | Raises | Buy | $230.00 | $180.00 |
| Matt Summerville | DA Davidson | Raises | Buy | $240.00 | $235.00 |
| Richard Eastman | Baird | Raises | Neutral | $204.00 | $198.00 |
| Julian Mitchell | Barclays | Raises | Equal-Weight | $205.00 | $200.00 |
| Deane Dray | RBC Capital | Raises | Outperform | $229.00 | $212.00 |
| Steve Barger | Keybanc | Raises | Overweight | $220.00 | $205.00 |
Key Insights:
- Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to AMETEK. This offers insight into analysts' perspectives on the current state of the company.
- Rating: Analysts unravel qualitative evaluations for stocks, ranging from 'Outperform' to 'Underperform'. These ratings offer insights into expectations for the relative performance of AMETEK compared to the broader market.
- Price Targets: Analysts provide insights into price targets, offering estimates for the future value of AMETEK's stock. This comparison reveals trends in analysts' expectations over time.
Analyzing these analyst evaluations alongside relevant financial metrics can provide a comprehensive view of AMETEK's market position. Stay informed and make data-driven decisions with the assistance of our Ratings Table.
Stay up to date on AMETEK analyst ratings.
Discovering AMETEK: A Closer Look
Founded in 1930 and transformed over the decades through the acquisition of dozens of esteemed brands, Ametek owns a collection of over 40 autonomous industrial businesses operating within the research, aerospace, energy, medical, and manufacturing industries. Ametek segments its business into two operating groups: the electronic instruments group and the electromechanical group. The EIG sells a broad portfolio of analytical, test, and measurement instruments, while the EMG sells highly engineered components, interconnects, and specialty metals. The company emphasizes product differentiation and market leadership in the niche markets where it operates.
Understanding the Numbers: AMETEK's Finances
Market Capitalization Analysis: Above industry benchmarks, the company's market capitalization emphasizes a noteworthy size, indicative of a strong market presence.
Revenue Growth: AMETEK displayed positive results in 3M. As of 30 September, 2025, the company achieved a solid revenue growth rate of approximately 10.77%. This indicates a notable increase in the company's top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Industrials sector.
Net Margin: AMETEK's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 19.62% net margin, the company effectively manages costs and achieves strong profitability.
Return on Equity (ROE): AMETEK's ROE stands out, surpassing industry averages. With an impressive ROE of 3.55%, the company demonstrates effective use of equity capital and strong financial performance.
Return on Assets (ROA): AMETEK's ROA excels beyond industry benchmarks, reaching 2.36%. This signifies efficient management of assets and strong financial health.
Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 0.23.
Analyst Ratings: Simplified
Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Latest Ratings for AME
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Jan 2022 | Morgan Stanley | Maintains | Overweight | |
| Dec 2021 | Mizuho | Initiates Coverage On | Buy | |
| Dec 2021 | Wolfe Research | Upgrades | Peer Perform | Outperform |
Posted-In: BZI-AARAnalyst Ratings


